Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 172 publications
Antibody E06 and the Role of Oxidized Phospholipids in Atherogenesis and Inflammation.
Journal: Circulation research
Published: June 04, 2026
Oxidized Phospholipids, Lipoprotein(a), and Cardiovascular Outcomes After Acute Coronary Syndrome.
Journal: Circulation
Published: December 01, 2025
Therapeutic Plasma Exchange and Evinacumab for Homozygous Familial Hypercholesterolemia.
Journal: JACC. Case reports
Published: October 10, 2025
Tissue tension fosters macrophage-driven lipid peroxidation-induced DNA damage.
Journal: Cancer cell
Published: June 25, 2025
Brief communication: Strong concordance of the North American Familial Chylomicronemia Syndrome Score with a positive genetic diagnosis in patients from the Balance study.
Journal: Journal of clinical lipidology
Published: June 07, 2025
Corrigendum to "Familial chylomicronemia syndrome and treatments to target hepatic APOC3 mRNA" [Atherosclerosis (2025) 403 119114].
Journal: Atherosclerosis
Published: May 02, 2025
Differential effects of volanesorsen on apoC-III, triglycerides, and pancreatitis in familial chylomicronemia syndrome diagnosed by genetic or nongenetic criteria.
Journal: Journal of clinical lipidology
Published: November 18, 2024
Familial chylomicronemia syndrome and treatments to target hepatic APOC3 mRNA.
Journal: Atherosclerosis
Published: August 22, 2024
Time-Restricted Feeding Reduces Atherosclerosis in LDLR KO Mice but Not in ApoE Knockout Mice.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: August 01, 2024
Oxidized phosphatidylcholines deposition drives chronic neurodegeneration in a mouse model of progressive multiple sclerosis via IL-1β signaling.
Journal: Nature neuroscience
Published: July 24, 2024
Olezarsen, Acute Pancreatitis, and Familial Chylomicronemia Syndrome.
Journal: The New England journal of medicine
Published: April 08, 2024
Corrigendum to "Volanesorsen and triglyceride levels in familial chylomicronemia syndrome: Long-term efficacy and safety data from patients in an open-label extension trial" [Journal of Clinical Lipidology, Volume 17, Issue 3, May-June 2023, Pages 342-355].
Journal: Journal of clinical lipidology
Published: April 02, 2024
Last Updated: 09/26/2026